Key result
Automatic ECG-based LVH detection predicts ~153% higher CV mortality in hemodialysis patients.
Why the study?
Manual annotation of ECG-based LVH parameters is cumbersome, prompting the need to compare an automated approach against manual measurements and assess its predictive value for mortality in ESKD.
Is automatic ECG-based detection of left ventricular hypertrophy as reliable as manual measurement for risk prediction in ESKD patients undergoing haemodialysis?
Cohort (n=301)
Yes
Is automatic ECG-based detection of left ventricular hypertrophy as reliable as manual measurement for risk prediction in ESKD patients undergoing haemodialysis?
Automatic ECG algorithms can reliably assess LVH parameters and predict mortality risk as effectively as manual measurements in haemodialysis patients.
May support automated LVH detection for mortality risk stratification in haemodialysis; leaves open prospective validation vs manual methods.
Objective. Left ventricular hypertrophy (LVH) is one of the most severe risk factors in patients with end-stage kidney disease (ESKD) regarding all-cause and cardiovascular mortality. It contributes to the risk of sudden cardiac death which accounts for approximately 25% of deaths in ESKD patients. Electrocardiography (ECG) is the least expensive way to assess whether a patient has LVH, but manual annotation is cumbersome. Thus, an automated approach has been developed to derive ECG-based LVH parameters. The aim of the current study is to compare automatic to manual measurements and to investigate their predictive value for cardiovascular and all-cause mortality. Approach. From the 12-lead 24 h ECG measurements of 301 ESKD patients undergoing haemodialysis, three different LVH parameters were calculated. Peguero-Lo Presti voltage, Cornell voltage, and Sokolow–Lyon voltage were automatically derived and compared to the manual annotations. To determine the agreement between manual and automatic measurements and their predictive value, Bland–Altman plots were created and Cox regression analysis for cardiovascular and all-cause mortality was performed. Main results. The median values for the automatic assessment were: Peguero-Lo Presti voltage 1.76 mV (IQR 1.29–2.55), Cornell voltage 1.14 mV (IQR 0.721–1.66), and Sokolow–Lyon voltage 1.66 mV (IQR 1.08–2.23). The mean differences when compared to the manual measurements were −0.027 mV (0.21 SD), 0.027 mV (0.13 SD) and −0.025 mV (0.24 SD) for Peguero-Lo Presti, Cornell, and Sokolow–Lyon voltage, respectively. The categorial LVH detection based on pre-defined thresholds differed in only 13 cases for all indices between manual and automatic assessment. Proportional hazard ratios only differed slightly in categorial LVH detection between manually and automatically determined LVH parameters; no differences could be found for continuous parameters. Significance. This study provides evidence that automatic algorithms can be as reliable in LVH parameter assessment and risk prediction as manual measurements in ESKD patients undergoing haemodialysis.
No takes yet. Share an insight, caveat, or question.
Letz et al. (2023) conducted a cohort in End-stage kidney disease (ESKD) undergoing haemodialysis (n=301). Automatic ECG-based detection of LVH parameters vs. Manual ECG-based detection of LVH parameters was evaluated on Cardiovascular mortality (automatic Peguero-Lo Presti voltage, categorial) (HR 2.53, 95% CI 1.12, 5.70, p=0.025). Automatic ECG-based detection of left ventricular hypertrophy parameters reliably predicted cardiovascular mortality in haemodialysis patients, with automatic Peguero-Lo Presti voltage yielding an HR of 2.53.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: